All News

CMS extends deadline for using new Medicare form

US Oncology, a cancer treatment and research network that also acts as a distributor, is implementing an electronic pedigree data management solution.

The Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 was introduced last week in the House of Representatives.

Long-term care pharmacists on the East Coast are invited to attend an upcoming senior symposium.

U.S. prescription sales grew by 8.3%, to $274.9 billion, from 2005 to 2006.

NACDS applauded 46 senators for their leadership in opposition to a proposed rule that could threaten the existence of retail pharmacies, particularly in rural areas and severely restrict the ability of millions of Medicaid beneficiaries to access prescription drugs from retail pharmacies.

Stronger warnings for the labeling for 13 sedative-hypnotics were recently requested by the FDA.

ISA247, a calcineurin inhibitor currently in phase IIb in North America for the prevention of organ rejection in kidney transplant patients and as a treatment for uveitis, has received approval from the United States Adopted Names Council to call the drug voclosporin.

The FDA has issued a public health advisory about revised product labeling for erythropoiesis-stimulating agents (ESAs), including darbepoetin (Aranesp, Amgen) and epoetin alfa (Epogen, Amgen; Procrit, Ortho Biotech).

When Carl Dew was in the seventh grade, his teacher asked the class to practice filling out a job application. "I wrote the application to Lane Drug Co. in Knoxville," said Dew, owner of Corner Drug Store in Lake City, Tenn.

For 171 years a Thompson has been behind the counter at Thompson Drugs. Six generations of Heimstreets have counseled patients. The fourth generation of Seiferts recently began practice as a pharmacist, while Rupal Patel, a professor of pharmacy, is following the trail her grandfather blazed ... in India.

Generic drug industry movers and shakers believe 2007 will be the year affordable generic biopharmaceuticals will reach consumers. "We are on the verge of a new revolution in our industry, and that's the creation of a clear and effective abbreviated pathway to biogenerics," GPhA president and CEO Kathleen Jaeger told attendees at GPhA's annual meeting in Phoenix. Rep. Henry Waxman (D, Calif.) and Sen.